Cancer Stem Cells Market Size, Share, By Product (Cell-Culturing, and Cell-Separation, Cell Analysis, Molecular Analysis, and Others), Mode of Action (Targeted Cancerous Stem Cell [CSCs] and Stem Based Cancer Therapy), Cell Source (Adipose Tissue, Bone Ma
Description
Cancer Stem Cells Market Size, Share, By Product (Cell-Culturing, and Cell-Separation, Cell Analysis, Molecular Analysis, and Others), Mode of Action (Targeted Cancerous Stem Cell [CSCs] and Stem Based Cancer Therapy), Cell Source (Adipose Tissue, Bone Marrow, and Placenta/Umbilical Cord), Cancer Type (Breast Cancer, Lung Cancer, Blood Cancer, Bladder Cancer, Liver Cancer, and Others), End-User (Hospitals & Cancer Treatment Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), and Others), and Region - Trends, Analysis, and Forecast till 2035
Stem Cells are the cells from which other types of cells with specialized functions are generated. Cancer Stem Cell studies help to understand root cause and understand how cancer disease occurs, they also help in treating people with lymphoma and leukemia.
Growing investment of major companies in stem cell project has fueled the market growth. New product launched, merger and acquisition of companies to expand its stem cell portfolio is expected to foster the demand for Cancer Stem Cells market growth in coming years.
The report “Cancer Stem Cells Market, By Cancer Type (Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others), By Mode of Action (Targeted CSCs, Stem Cell based Cancer Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”
Key Highlights:
The key factor driving the growth of the Cancer Stem Cells Market is growing prevalence of cancer diseases. Advantages of autologous transplant and improved survival rate of patients has further, enhanced the market growth. Technological advancement is expected to boost the demand for Cancer Stem Cells market growth in future. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.
Key Market Insights from the report:
Cancer Stem Cells Market accounted for US$ 1.4 billion in 2024 and is estimated to be US$ 4 billion by 2034 and is anticipated to register a CAGR of 1.50%. The Cancer Stem Cells Market is segmented based on Cancer Type, Mode of Action and Region.
The prominent players operating in the Cancer Stem Cells Market includes, AbbVie Inc., Thermo Fisher Scientific Inc., Merck KGaA, Stemline Therapeutics Inc., OncoMed Pharmaceuticals Inc., PromoCell GmbH, Miltenyi Biotec, Irvine Scientific, Sino Biological Inc., STEMCELL Technologies Inc., and others.
Key Questions Answered:
Stem Cells are the cells from which other types of cells with specialized functions are generated. Cancer Stem Cell studies help to understand root cause and understand how cancer disease occurs, they also help in treating people with lymphoma and leukemia.
Growing investment of major companies in stem cell project has fueled the market growth. New product launched, merger and acquisition of companies to expand its stem cell portfolio is expected to foster the demand for Cancer Stem Cells market growth in coming years.
The report “Cancer Stem Cells Market, By Cancer Type (Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others), By Mode of Action (Targeted CSCs, Stem Cell based Cancer Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”
Key Highlights:
- In June 2021, Jasper Therapeutics Inc., and Amplitude Healthcare Acquisition Corporation has announced its merger acquisition to create Biotechnology Company in Hematopoietic Stem Cell Transplantation.
- FUJIFILM Irvine Scientific.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- MacroGenics, Inc.
- R&D Systems, Inc.
- Miltenyi Biotec
- Bio-Techne
- AbbVie Inc.
- STEMCELL Technologies
- Merriam-Webster, Incorporated
- PromoCell
- Lonza
- Lineage Cell Therapeutics, Inc.
- Sino Biological, Inc.
- The Menarini Group
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2035.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
- Market intelligence to enable effective decision-making
- Growth opportunities and trend analyses
- Market estimates and forecasts from 2025 to 2035
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
The key factor driving the growth of the Cancer Stem Cells Market is growing prevalence of cancer diseases. Advantages of autologous transplant and improved survival rate of patients has further, enhanced the market growth. Technological advancement is expected to boost the demand for Cancer Stem Cells market growth in future. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.
Key Market Insights from the report:
Cancer Stem Cells Market accounted for US$ 1.4 billion in 2024 and is estimated to be US$ 4 billion by 2034 and is anticipated to register a CAGR of 1.50%. The Cancer Stem Cells Market is segmented based on Cancer Type, Mode of Action and Region.
- Based on Cancer Type, Cancer Stem Cells Market is segmented into Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others.
- Based on Mode of Action, Cancer Stem Cells Market is segmented into Targeted CSCs, Stem Cell based Cancer Therapy.
- By Region, the Cancer Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
The prominent players operating in the Cancer Stem Cells Market includes, AbbVie Inc., Thermo Fisher Scientific Inc., Merck KGaA, Stemline Therapeutics Inc., OncoMed Pharmaceuticals Inc., PromoCell GmbH, Miltenyi Biotec, Irvine Scientific, Sino Biological Inc., STEMCELL Technologies Inc., and others.
Key Questions Answered:
- How is the Cancer Stem Cells Market expected to evolve by 2035?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2035?
- Who are the leading players in the market, and what are their prospects?
Table of Contents
170 Pages
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By Mode of Action
- Market Snippet, By Cell Source
- Market Snippet, By Cancer Type
- Market Snippet, By End-User
- Market Snippet, By Region
- Self-levelling Pendulum
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Mode of Action Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Etiology of Cancer
- Cancer Risk Assessment
- Tumor Profiling
- Market Segmentation, By Product, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Cell-Culturing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cell-Separation
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cell Analysis
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Molecular Analysis
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Mode of Action, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Targeted Cancerous Stem Cell [CSCs]
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Anti-CSC Therapeutics
- Surface Marker-Based
- Stem Based Cancer Therapy
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Autologous SC Transplant
- Allogeneic SC Transplant
- Market Segmentation, By Cell Source, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Adipose Tissue
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Bone Marrow
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Placenta/Umbilical Cord
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Cancer Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Breast Cancer
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Lung Cancer
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Blood Cancer
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Bladder Cancer
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Liver Cancer
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals & Cancer Treatment Centers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnosis Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Academic & Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode of Action, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cell Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cancer Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode of Action, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cell Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cancer Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode of Action, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cell Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cancer Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode of Action, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cell Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cancer Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Mode of Action, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cell Source, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Cancer Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- FUJIFILM Irvine Scientific.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- MacroGenics, Inc.
- R&D Systems, Inc
- Miltenyi Biotec
- Bio-Techne
- AbbVie Inc.
- STEMCELL Technologies
- Merriam-Webster, Incorporated
- PromoCell
- Lonza
- Lineage Cell Therapeutics, Inc.
- Sino Biological, Inc.
- The Menarini Group
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
